Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?

Chu, E C

Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action? [electronic resource] - Alimentary pharmacology & therapeutics Jun 2007 - 1443-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0269-2813

10.1111/j.1365-2036.2007.03336.x doi


Annexin A5--pharmacology
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Apoptosis--drug effects
Blotting, Western--methods
Colitis, Ulcerative--drug therapy
Colonic Neoplasms--metabolism
Down-Regulation
Enzyme Inhibitors--pharmacology
Gene Expression--drug effects
Humans
Immunohistochemistry--methods
Mesalamine--pharmacology
Proto-Oncogene Proteins c-myc--metabolism
Treatment Outcome